Quality Control of 2,5-DibromopyridineIn 2020 ,《Synthesis of Pyridoclax Analogues: Insight into Their Druggability by Investigating Their Physicochemical Properties and Interactions with Membranes》 appeared in ChemMedChem. The author of the article were De Pascale, Martina; Iacopetta, Domenico; Since, Marc; Corvaisier, Sophie; Vie, Veronique; Paboeuf, Gilles; Hennequin, Didier; Perato, Serge; De Giorgi, Marcella; Sinicropi, Maria Stefania; Sopkova-De Oliveira Santos, Jana; Voisin-Chiret, Anne-Sophie; Malzert-Freon, Aurelie. The article conveys some information:
Pyridoclax is considered a promising anticancer drug, acting as a protein-protein interaction disruptor, with potential applications in the treatment of ovarian, lung, and mesothelioma cancers. Eighteen sensibly selected structural analogs of Pyridoclax were synthesized, and their physicochem. properties were systematically assessed and analyzed. Moreover, considering that drug-membrane interactions play an essential role in understanding the mode of action of a given drug and its eventual toxic effects, membrane models were used to investigate such interactions in bulk (liposomes) and at the air-water interface. The measured exptl. data on all original oligopyridines allowed the assessment of relative differences in terms of physicochem. properties, which could be determinant for their druggability, and hence for drug development. In the experiment, the researchers used 2,5-Dibromopyridine(cas: 624-28-2Quality Control of 2,5-Dibromopyridine)
2,5-Dibromopyridine(cas: 624-28-2) belongs to pyridine. The basicity and metallophilic high donor number of these π-deficient systems has long favored them as ligands in metal catalysis. The last decade saw pyridine assume a stronger role as functional group for directed C–H oxidation/activation.Quality Control of 2,5-Dibromopyridine